Exactech Welcomes Aurelio Sahagun as New CEO Amid Transition

In a significant transition for the global medical technology leader Exactech, Aurelio Sahagun has been appointed as the new Chief Executive Officer, set to take the helm upon the closing of a company sale expected as soon as October. This pivotal change follows the leadership of Darin Johnson, who has been at the forefront for six years, instrumental in shaping the company’s vision and strategy.

A New Leader with Extensive Experience

Aurelio Sahagun brings over two decades of valuable experience in the medical device industry, with a history of success in driving product development and financial performance. His most recent role was as the President of North America for the Straumann Group, a recognized leader in orthodontic solutions and implants. There, he played a crucial role in achieving double-digit sales growth and enhancing profitability.

Before his tenure at Straumann, Sahagun held leadership roles at Microport Orthopedics, Wright Medical Technology, and Medtronic, further solidifying his expertise in managing and executing strategic initiatives within the medical devices sector.

Darin Johnson voiced his confidence in Sahagun, stating, "Aurelio is well-equipped to lead the new company with his vast experience in driving excellent results for innovative medical devices and implants. His people-first approach aligns perfectly with Exactech's culture and core values." This sentiment is critical as the company transitions into a new phase under new ownership.

Focus on Innovation and Growth

Sahagun expressed enthusiasm about joining Exactech at this pivotal moment. "The people, products, and culture cultivated over our 40-year history are recognized across the industry and will bolster the mission and success of the 'new Exactech'," he remarked. His focus will be on executing strategic priorities, continuing the success of the impressive product portfolio, and ensuring strong financial performance.

Moreover, Clara Anderson, Managing Director at Strategic Value Partners (SVP), expressed faith in Sahagun’s leadership abilities, stating, "Aurelio is an exceptional leader who joins at a time when Exactech is poised to achieve an industry-leading standard of quality across manufacturing and its broader operations."

Strategic Transition and Investment

This leadership change comes amidst a broader restructuring phase for Exactech. In March, a consortium of investors, including SVP, Stellex Capital Management LLC, and Greywolf Capital Management LP, was named the winning bidder for substantially all of Exactech's operations and assets. This investment aims to unlock further potential within the company’s operations and accelerate growth opportunities.

Aurelio Sahagun holds a bachelor's degree in Economics from the University of Madrid and a Master's in Business Administration from HEC Paris. He will be based at Exactech's headquarters in Gainesville, Florida, where he plans to leverage his extensive knowledge and experience to guide the new company's direction.

The leadership transition aligns with a commitment to enhancing the company’s positioning within the medical technology landscape, focusing on innovative solutions that empower orthopedic surgeons and improve patient outcomes.

Exactech, which specializes in developing innovative implants, surgical instruments, and a comprehensive AI ecosystem known as Active Intelligence®, continues to be dedicated to meeting the needs of both surgeons and patients effectively. This new chapter under Sahagun’s leadership promises a bright future for Exactech in delivering superior orthopedic solutions.

For more information on Exactech and its latest developments, visit their website and connect through their social media platforms including LinkedIn, Vumedi, YouTube, Instagram, and X.